These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 31299378)
1. Evaluation of 5-hydroxy-1,4-naphthoquinone-cobalt(III) complexes for hypoxia-activated drug delivery. de Mello MVP; Cebrián-Torrejón G; Pereira JR; Dos Santos Moreira C; Gomes CBSMR; da Rocha DR; de Souza Fagundes EM; Ferreira GB; Lanznaster M J Inorg Biochem; 2019 Oct; 199():110756. PubMed ID: 31299378 [TBL] [Abstract][Full Text] [Related]
2. A study on the properties and reactivity of naphthoquinone-cobalt(III) prototypes for bioreductive prodrugs. Bustamante FL; Miranda FS; Castro FA; Resende JA; Pereira MD; Lanznaster M J Inorg Biochem; 2014 Mar; 132():37-44. PubMed ID: 24326134 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of cobalt(III) complexes as potential hypoxia-responsive carriers of esculetin. Palmeira-Mello MV; Caballero AB; Ribeiro JM; de Souza-Fagundes EM; Gamez P; Lanznaster M J Inorg Biochem; 2020 Oct; 211():111211. PubMed ID: 32805459 [TBL] [Abstract][Full Text] [Related]
4. Cross-bridged cyclen or cyclam Co(III) complexes containing cytotoxic ligands as hypoxia-activated prodrugs. Chang JY; Lu GL; Stevenson RJ; Brothers PJ; Clark GR; Botting KJ; Ferry DM; Tercel M; Wilson WR; Denny WA; Ware DC Inorg Chem; 2013 Jul; 52(13):7688-98. PubMed ID: 23773210 [TBL] [Abstract][Full Text] [Related]
5. Investigation of cobalt(iii)-triazole systems as prototypes for hypoxia-activated drug delivery. de Souza IC; Faro LV; Pinheiro CB; Gonzaga DT; da Silva Fde C; Ferreira VF; Miranda Fda S; Scarpellini M; Lanznaster M Dalton Trans; 2016 Sep; 45(35):13671-4. PubMed ID: 27488398 [TBL] [Abstract][Full Text] [Related]
6. Towards targeting anticancer drugs: ruthenium(ii)-arene complexes with biologically active naphthoquinone-derived ligand systems. Kubanik M; Kandioller W; Kim K; Anderson RF; Klapproth E; Jakupec MA; Roller A; Söhnel T; Keppler BK; Hartinger CG Dalton Trans; 2016 Aug; 45(33):13091-103. PubMed ID: 27214822 [TBL] [Abstract][Full Text] [Related]
8. Bis(dialkyl)dithiocarbamato cobalt(III) complexes of bidentate nitrogen mustards: synthesis, reduction chemistry and biological evaluation as hypoxia-selective cytotoxins. Ware DC; Palmer HR; Pruijn FB; Anderson RF; Brothers PJ; Denny WA; Wilson WR Anticancer Drug Des; 1998 Mar; 13(2):81-103. PubMed ID: 9524553 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization and cytotoxicity studies of Co(III)-flavonolato complexes. Kozsup M; Zhou X; Farkas E; Bényei AC; Bonnet S; Patonay T; Kónya K; Buglyó P J Inorg Biochem; 2021 Apr; 217():111382. PubMed ID: 33588278 [TBL] [Abstract][Full Text] [Related]
10. Copper(II), cobalt(II) and nickel(II) complexes of juglone: synthesis, structure, DNA interaction and enhanced cytotoxicity. Tabrizi L; Fooladivanda M; Chiniforoshan H Biometals; 2016 Dec; 29(6):981-993. PubMed ID: 27613275 [TBL] [Abstract][Full Text] [Related]
11. A series of mononuclear Co(III) complexes using tridentate N,O-donor ligands: chemical properties and cytotoxicity activity. Souza ET; Maia PJ; Azevedo EM; Kaiser CR; Resende JA; Pinheiro CB; Heinrich TA; da Silva RS; Scarpellini M J Inorg Biochem; 2011 Dec; 105(12):1767-73. PubMed ID: 22001498 [TBL] [Abstract][Full Text] [Related]
12. Cobalt complexes with pyrazole ligands as catalyst precursors for the peroxidative oxidation of cyclohexane: X-ray absorption spectroscopy studies and biological applications. Silva TF; Martins LM; Guedes da Silva MF; Kuznetsov ML; Fernandes AR; Silva A; Pan CJ; Lee JF; Hwang BJ; Pombeiro AJ Chem Asian J; 2014 Apr; 9(4):1132-43. PubMed ID: 24482364 [TBL] [Abstract][Full Text] [Related]
13. Investigation of cobalt(III)-phenylalanine complexes for hypoxia-activated drug delivery. de Souza ICA; Santana SS; Gómez JG; Guedes GP; Madureira J; Quintal SMO; Lanznaster M Dalton Trans; 2020 Nov; 49(45):16425-16439. PubMed ID: 32692333 [TBL] [Abstract][Full Text] [Related]
14. Optimization of the auxiliary ligand shell of Cobalt(III)(8-hydroxyquinoline) complexes as model hypoxia-selective radiation-activated prodrugs. Ahn GO; Ware DC; Denny WA; Wilson WR Radiat Res; 2004 Sep; 162(3):315-25. PubMed ID: 15333003 [TBL] [Abstract][Full Text] [Related]